Jonathan Allan - 03 Dec 2024 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role: GENERAL COUNSEL & CORP SEC
Signature: /s/ Jonathan Allan
Issuer symbol: STOK
Transactions as of: 03 Dec 2024
Net transactions value: $0
Form type: 4
Filing time: 05 Dec 2024, 16:21:07 UTC
Previous filing: 03 Dec 2024
Next filing: 10 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	STOK	Common Stock	Options Exercise	$0	+6,000	+15%	$0.000000	44,838	03 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STOK	Performance Stock Units	Award	$0	+12,000		$0.000000	12,000	03 Dec 2024	Common Stock	12,000		Direct	F1, F2, F3
transaction	STOK	Performance Stock Units	Options Exercise	$0	-6,000	-50%	$0.000000	6,000	03 Dec 2024	Common Stock	6,000		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each performance stock unit represents a right to receive one share of the Issuer's common stock.
F2	This award represents a grant of restricted stock units upon the achievement of certain performance criteria as certified by the Issuer's compensation committee on the Transaction Date.
F3	Half the award vests on December 3, 2024 and the remainder shall vest on December 3, 2025, subject to the reporting person's continued service to the Issuer on the relevant vesting date.